Sponsor
Atrogi AB
Tomtebodavagen 6, 171 65 Solna, Sweden
About the sponsor
Atrogi AB’s clinical research is centred on type 2 diabetes, with interest in therapies that address metabolic control and the management of glycaemic regulation.
- Type 2 diabetes treatment
- Metabolic disease
- Blood glucose control
The sponsor’s research activity reflects a focus on endocrinology and diabetes therapeutics, particularly oral treatment approaches relevant to chronic metabolic disease.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.